Germ cell nuclear factor (GCNF) is a transcription factor that can repress gene transcription and plays an important role during spermatogenesis. Peroxisome proliferatoractivated receptor delta (PPARδ) is a nuclear hormone receptor belonging to the steroid receptor superfamily. It can activate the expression of many genes, including those involved in lipid metabolism. In this report, we showed that GCNF specifically interacts with PPARδ promoter. Overexpression of GCNF in African green monkey SV40-transformed kidney fibroblast COS7 cells and mouse embryo fibroblast NIH 3T3 cells represses the activity of PPARδ promoter. The mutation of GCNF response element in PPARδ promoter relieves the repression in NIH 3T3 cells and mouse testis. Moreover, we showed that GCNF in nuclear extracts of mouse testis is able to bind to PPARδ promoter directly. We also found that GCNF and PPARδ mRNA were expressed with different patterns in mouse testis by in situ hybridization. These results suggested that GCNF might be a negative regulator of PPARδ gene expression through its direct interaction with PPARδ promoter in mouse testis.
of mouse GCNF has shown that the gene is crucial for embryonic viability. GCNF-deficient embryos die at approximately 10.5th day of embryo stage due to cardiovascular complications [19] . It has been shown that GCNF is important for male reproduction. Until now, it has been known that the developmental program of spermatogenesis is regulated by GCNF and several other transcription factors such as cAMP-response element modulator (CREM) [20] . In the testis, GCNF is highly expressed in stage II−IV pachytene spermatocytes but not in Sertoli cells [21] .
In this report, based on the existence of putative DNA binding sites of GCNF in the PPARδ promoter, we showed that GCNF-dependent repression of PPARδ gene expression is driven by a GCNF response element located within the PPARδ promoter in mouse testis.
Materials and Methods

Animals and treatments
Mature male mice (Kongmin White outbred strain) were fed in a controlled environment with a 14:10 h light/dark cycle.
Plasmids, cells, and antibodies
The plasmid containing the PPARδ promoter was named pGLPP [22] . To mutate the GCNF DNA binding sites in PPARδ promoter, an overlapping PCR was carried out using pGLPP as the template. The primer pairs were 5′-TGAAGCCCTTGTTCCATACTC-3′ (Fpp) and 5′-GTGGAGGGTCTCGAAGCTGGTCTgtcACTCCTG-3′ for primer 1, 5′-CAGGAGTgacAGACCAGCTTCG-AGACCCTCCAC-3′ and 5′-CTGTCCCGGCCGCCT-CTCGC-3′ (Rpp) for primer 2, and Fpp and Rpp for primer 3. PCR procedures were set as follows: 32 cycles at 94 ºC for 45 s, 55 ºC for 45 s, and 72 ºC for 60 s. PCR products of primers 1 and 2 were purified by a gel recovering kit (Dingguo Biotech, Beijing, China). The overlapping PCR was carried out using the two recovered PCR fragments (mixed at a ratio of 1:1) and primer 3. The PCR procedure was 35 cycles at 94 ºC for 45 s, 58 ºC for 45 s, and 72 ºC for 60 s. The PCR product of primer 3 was also cloned into pGEM-T Easy vector (Promega, Madison, USA). The wild-type promoter and the mutated promoter of the GCNF binding site were sequenced by Sunbio Biotechniques (Beijing, China). The murine 2000 bp DNA fragment and mutated fragment with GCNF binding site were then subcloned into the NheI and SmaI sites in pGL2-Basic Vector (Promega) and named pGLPP and pGLmPR, respectively. The eukaryotic GCNF expression vector pGCNF and antibody to mouse GCNF were generous gifts from Dr. Uwe Borgmeyer (Hamburg University, Hamburg, Germany).
The mouse embryo fibroblast cell line NIH 3T3 and African green monkey SV40-transformed kidney fibroblast cell line COS7 were cultured in high glucose Dulbecco's modified Eagle's medium (Life Technologies, Rockville, USA). All culture media were supplemented with 10% (V/V) fetal bovine serum at 37 ºC with 5% CO 2 . Plasmid DNA used for transfection was prepared using the Wizard Plus SV Minipreps DNA Purification System (Promega).
Transcription factor analysis
To analyze the transcription factors in PPARδ promoter, an online tool, TRANSFAC transcription factor database (http://www.gene-regulation.com/pub/databases.html), was used. A 2.0 kb fragment of PPARδ promoter was scanned. Promoter and transcription factor binding site analysis was carried out using MatInspector software (http://www.genomatix.de/products/ MatInspector/index. html) and the Match tool (http://www.biobase.de).
Assay of promoter activity
For promoter activity analysis, NIH 3T3 and COS7 cells were seeded onto 24-well plates (Costar, Corning, USA) at the required density of approximately 5×10 4 cells/ml. Eighteen hours later, cells were co-transfected with the luciferase reporter constructs and the pRL-TK plasmid (internal control) using the Lipofectamine 2000 Reagent (Life Technologies) according to the manufacturer's protocols. Briefly, when cells were 90%−95% confluent, 630 ng plasmid DNA (containing pRL-TK, pGLPP/ pGLmPR, and pcDNA3.1) and 5 μl Lipofectamine 2000 were diluted in 100 μl serum-free Dulbecco's modified Eagle's medium, mixed gently, and incubated for 20 min at room temperature. The complexes were added to each well, and mixed gently by rocking the plate back and forth. Twenty-four hours after transfection, cells were passively lysed for promoter assay. In overexpression analysis, pGCNF plasmids were co-transfected with pGLPP/ pGLmPR and pRL-TK, and the total amount of transfection plasmids was kept constant with the empty pcDNA vector. In co-transfection, the molar ratio of the recombinant plasmid to be assayed and pRL-TK plasmid was kept at 10:3. Luciferase activity was measured using a Dual Luciferase Assay System (Promega) according to the manufacturer's instructions. In brief, the culture medium was replaced with 100 μl passive lysis buffer (Promega), and the culture plate was placed on a rocking platform with gentle shaking at room temperature for 15 min to ensure complete and even coverage of the cells. Luciferase Assay Reagent II (100 μl; Promega) was predispensed into luminometer tubes and mixed with 20 μl cell lysis. Then the tubes were placed in the luminometer. After the firefly luciferase activity was measured, Stop & Glo Reagent (100 μl; Promega) was added to the tubes for measuring the Renilla luciferase activity. Three parallel experiments were carried out for statistical analysis. Results were expressed as the mean±SEM. Data were analyzed for statistical differences by the paired Student's t-test method. Differences were considered significant at P<0.05.
In vivo electroporation assay
Injection of the luciferase constructs and the pRL-TK control into mouse testes was carried out as previously described [23] with some modifications. Briefly, 50 μl plasmid solution containing 0.4% Trypan blue (Sigma, St. Louis, USA) was slowly injected using a 100 μl micro-injector [23] at a depth of 5−6 mm through the testis capsule of 3-month-old Kongmin White male mice. The molar ratio of the reporter plasmid and pRL-TK control was kept at 5:1. Forty-eight hours after testis injection, electroporated testes were excised then homogenized in a mortar with lysis buffer under liquid nitrogen. The pellets were resuspended in 200 μl passive lysis buffer then subjected to luciferase assay using the Dual Luciferase Assay System (Promega) according to the manufacturer's instructions. Three parallel experiments were carried out for statistical analysis. Results were expressed as the mean±SEM. Data were analyzed for statistical differences by the paired Student's t-test method.
In situ hybridization Digoxigenin (DIG)-labeled antisense or sense cRNA probes were transcribed in vitro using a DIG RNA labeling kit (T7 for sense and SP6 for antisense; Boehringer Mannheim, Mannheim, Germany). GCNF was amplified with primer pair 5′-GAGCGGGACGAACGGCC-3′ and 5′-CACTCCTTCACCGTACTTGT-3′. For PPARδ, total RNA from mouse testis were reverse transcribed and amplified with forward primer 5′-GAGGAGAAAGAG-GAAGTGG-3′ and reverse primer 5′-CCACCAGCT-TCCTCTTCTC-3′ designed according to PPARδ (295− 724 bp; GenBank accession No. U40064). Both GCNF and PPARδ were cloned into pGEM-T and DIG-labeled antisense or sense GCNF and PPARδ cRNA probes were obtained. The cloned GCNF and PPARδ fragments were further verified by sequencing and matched with the corresponding region of GCNF and PPARδ sequences, respectively.
Testes were cut into 4−6 mm pieces and flash frozen in liquid nitrogen. Frozen sections (10 μm) were mounted on slides coated with 3-aminopropyltriethoxy-silane (Sigma) and fixed in 4% paraformaldehyde solution in phosphate-buffered saline (PBS). The sections were washed in PBS twice, treated with 1% Triton X-100 for 20 min, and washed another three times in PBS. After prehybridization in a solution of 50% formamide and 5×sodium chloride sodium citrate (SSC) (1×SSC is 0.15 M sodium chloride and 0.015 M sodium citrate) at room temperature for 15 min, the sections were hybridized in the hybridization buffer (5×SSC, 50% formamide, 0.02% bovine serum albumin, 250 μg/ml yeast tRNA, 10% dextran sulfate, and 1 μg/ml denatured DIG-labeled antisense or sense cRNA probe for mouse GCNF) at 55 ºC for 16 h. After hybridization, the sections were washed in 50% formamide/5×SSC at 55 ºC for 15 min, 50% formamide/2×SSC at 55 ºC for 30 min, 50% formamide/ 0.2×SSC at 55 ºC twice for 30 min each, and 0.2×SSC at room temperature for 5 min. After non-specific binding was blocked in 1% block mix (Boehringer Mannheim) for 1 h, the sections were incubated in sheep anti-DIG antibody conjugated with alkaline phosphatase (1:5000; Boehringer Mannheim) in 1% block mix overnight at 4 ºC. The signal was visualized with 0.4 mM 5-bromo-4-chloro-3-indolyl phosphate and 0.4 mM nitroblue tetrazolium in buffer containing 100 mM Tris-HCl (pH 9.5), 100 mM NaCl, and 50 mM MgCl 2 . Endogenous alkaline phosphatase activity was inhibited by 2 mM levamisole (Sigma). All sections were counterstained with 1% methyl green in 0.12 M glacial acetic acid and 0.08 M sodium acetate for 30 min.
Electrophoretic mobility shift assay (EMSA)
Probe sequences of putative GCNF binding element were as follows (mutations are indicated by lowercase letters, with the first F indicating the forward primer and the first R indicating the reverse primer): FRWT, 5′-CAGGAG-TTCAAGACCAGCT-3′; RRWT, 5′-AGCTGGTCTTGA-ACTCCTG-3′; FRMT, 5′-CAGGAGTgacAGACCAGCT-3′; RRMT, 5′-AGCTGGTCTgtcACTCCTG-3′ according to the PPARδ promoter. The consensus GCNF response element sequences, FRcon, 5′-GTCAAGGTCAAG-GTCAAG-3′ and RRcon, 5′-CTTGACCTTGACCTT-GAC-3′ were also synthesized. Testis cell nuclear extracts were prepared as described by Dignam et al. [24] . EMSA was carried out using the Gel Shift Assay System (Promega) according to the manufacturer's protocol with minor modifications. Briefly, the sense and antisense strands were annealed and end-labeled with 32 P-ATP (3000 Ci/nM) (Furui Biotech, Beijing, China) using the T4 polynucleotide kinase. Nuclear extract protein (2−5 μg) was mixed with 5× binding buffer [20% glycerol, 5 mM MgCl 2 , 2.5 mM EDTA, 2.5 mM dithiothreitol, 250 mM NaCl, 50 mM Tris-HCl (pH 7.5), and 0.25 mg/ml poly(dI-dC)] and 32 P-labeled double-stranded oligonucleotide containing putative regulatory element as a probe. The testis cell nuclear extracts (200 ng) were mixed with putative GCNF binding sequences. In the competition or supershift experiments, excessive competitor or antibody to GCNF was pre-incubated with the nuclear extract before the addition of oligonucleotide probe. The samples were separated on 5% polyacrylamide gels in 0.5×Tris-borate-EDTA at 350 V, and the gels were dried and exposed for autoradiography at −70 ºC overnight.
Results
Mouse PPARδ promoter is repressed by GCNF in vitro
To determine whether GCNF is involved in the transcriptional regulation of the PPARδ gene, a 2.0 kb 5′-upstream nucleotide sequence of the major transcription start point of the murine PPARδ gene was analyzed using MatInspector software (http://www.genomatix.de/products/ MatInspector/index.html). It was predicted that there is a potential transcription factor binding site of GCNF in the 5′-flanking region GTCAAGGTCAAGGTCAAG (position −1800) (Fig. 1) . We constructed a plasmid, pGLPP, containing the 2.0 kb sequence in the 5′-flanking region and co-transfected this construct with a GCNF expression vector (pGCNF) and Renilla luciferase expression vector (pTK-Rluc) into NIH 3T3 and COS7 cells. As shown in Fig. 2 , GCNF significantly repressed the transcription activity of PPARδ promoter in the cells (P <0.05). Moreover, the repression depended on the concentration of plasmid pGCNF transfected into cells.
To investigate the mechanisms by which GCNF regulates PPARδ transcription, the ability of GCNF to directly regulate PPARδ transcription was further shown by disrupting the potential GCNF binding cis-element in PPARδ promoter. To test whether pGLmPR can be repressed by GCNF overexpression, we carried out cotransfection experiments similar to those carried out with wild-type PPARδ promoter and compared the effect of GCN F overexpression on t he mutant r eport er. Interestingly, as shown in Fig. 3 , although the pGLmPR vector was not repressed to the same extent as the wildtype vector, GCNF overexpression also repressed the activity of mutated PPARδ promoter, suggesting that the disruption of GCNF binding sites was only able to alleviate repression resulting from a direct interaction of GCNF with the promoter.
GCNF response element mutation reduces the repression activity of GCNF in vivo
Detailed functional analyses of promoters are usually carried out using cultured cells that transcribe the gene of interest. However, a culture system for spermatogenic cells is not currently available. In this study, to identify the essential elements for PPARδ transcription in male germ cells, we used an in vivo transient transfection technique in testicular germ cells, as described previously [23] . We introduced the plasmids that contained PPARδ promoters fused to a luciferase reporter into testicular germ cells using a combination of DNA injection into s eminifer ous tub ules a nd s ub seq uent in v iv o electroporation. The GCNF response element mutated plasmid pGLmPR, pGLPP, and pGL2-Basic were cotransfected with pRL-TK into testis cells by in vivo electroporation. The results are shown in Fig. 4 . The promoter of PPARδ was also functional in vivo as there is statistical difference between group pGLPP (Fig. 4,  column 2 ) and group pGL2-Basic (Fig. 4, column 3) (P=0.0285). The disruption of the GCNF putative binding site at the mouse PPARδ promoter resulted in visible increase in promoter activity compared with pGLPP (P=0.0508), consistent with the results in vitro (Fig. 3) . The data suggest that GCNF might also function through its response element in PPARδ promoter in testis.
GCNF in nuclear extracts of mouse testis is able to bind directly with the PPARδ promoter To determine whether GCNF directly regulates the activity of mouse PPARδ promoter in testis, EMSA was carried out using the nuclear extracts of mouse testis. As shown in Fig. 5 , GCNF could bind with its putative binding element in PPARδ promoter in the nuclear extracts of testis (Fig. 5, lane 2) . Further analysis of GCNF indicated that binding of the radioactive probe was successfully blocked by 100-fold molar excessive unlabeled GCNF response elements in the promoter (Fig. 5, lane 6 ) and GCNF response element consensus sequence (Fig. 5, lane  8) . As shown in Fig. 5 , the GCNF-GCNF response element complex migrated more slowly when the reaction was carried out in the presence of GCNF antibody (Fig. 5,  lane 1) , whereas no change in migration was observed without antibody to GCNF (Fig. 5, lane 2) . Moreover, non-specific oligonucleotide AP2 (Promega), YY1 (forward primer, 5′-TAGAGTGCCATCATGCCTTCCA- 
Fig. 4 Mutation in GCNF putative binding sites reduces GCNFmediated repression of the mouse PPARδ transcription in vivo
In the electroporation assay in vivo, plasmid pRL-TK was co-transfected with pGLmPR (column 1), pGLPP containing the PPARδ promoter (column 2), or pGL2-Basic (column 3) into mouse testis. The promoter functioned in testis as there was statistical difference between group pGLPP and group pGL2-Basic (*P=0.0285). The disruption of the GCNF putative binding site at the mouse PPARδ promoter resulted in visible increase in promoter activity (P=0.0508).
Fig. 5 GCNF binds to mouse
PPARδ promoter directly Electrophoretic mobility shift assay of the GCNF putative element probe+nuclear extracts of mouse testis. Lane 1, GCNF putative element probe+testis nuclear extracts+antibody to GCNF; lane 2, testis nuclear extracts+GCNF putative element probe; lane 3, GCNF putative element probe; lane 4, GCNF putative element probe+testis nuclear extracts+unspecific oligonucleotide AP2 competitor; lane 5, GCNF putative element probe+testis nuclear extracts+unspecific oligonucleotide YY1 competitor; lane 6, GCNF putative element probe+testis nuclear extracts+unlabeled GCNF putative element oligonucleotide competitor; lane 7, GCNF putative element probe+testis nuclear extracts+GCNF putative element mutated oligonucleotide competitor; lane 8, GCNF putative element probe+testis nuclear extracts+GCNF response element consensus sequence oligonucleotide competitor.
GA-3′; reverse primer, 5′-TCTGGAAGGCATGATGG-CACTCTA-3′), and GCNF response element mutated oligonucleotide could not block the binding of wild-type GCNF at all (Fig. 5, lanes 4 , 5, and 7, respectively). Taken together, we concluded that GCNF bound to its recognition sites in the upstream region of mouse PPARδ promoter.
Expression of PPARδ and GCNF in mouse testis
To determine the GCNF and PPARδ gene expression patterns in mouse testis, their expressions were detected by in situ hybridization. In adult mouse testis, GCNF mRNA was not detected in cells closest to the basal lamina, including spermatogonia, early spermatocytes, and supporting Sertoli cells, but only detected in the middle of the seminiferous tubule [ Fig. 6(B) ]. In contrast, expression of PPARδ mRNA was very weak in cells closest to the basal lamina [ Fig. 6(C) ]. The signal of PPARδ mRNA is very weak as detected by in situ hybridization, suggesting that the expression of the gene is low in mouse testis. In order to determine whether PPARδ was expressed in mouse testis, reverse transcription-PCR was carried out using cDNA from mouse testis. It was shown that mRNA of PPARδ could be found in mouse testis [ Fig. 6(C), lanes 2−4] .
Discussion
Spermatogenesis is a complex developmental process that includes the mitotic proliferation of spermatogonial stem cells, meiotic prophase, division of spermatocytes, replacement of histones during post-meiotic maturation, as well as the morphological changes of the haploid spermatids that ultimately lead to highly specialized motile spermato- zoa [9] . The developmental program of spermatogenesis is regulated by several transcription factors including GCNF [20] . Expression of GCNF is restricted to certain stages of spermatogenesis. We found GCNF mRNA centers in the middle of the seminiferous tubule by in situ hybridization. This expression pattern is similar to a previous report [21] . In spermatocytes, GCNF is first detected in pachytene spermatocytes at stages II−IV in a nuclear structure consistent with the XY-body that contains the condensed X and Y chromosomes. In post-meiotic round spermatids, GCNF mRNA levels peak at stages VII and VIII and markedly drop as the spermatid begins to elongate in stages IX and X [21, 25] . Several genes involved in spermatogenesis are regulated by GCNF. The PRM1 and PRM2 are two types of small basic proteins that replace the histones in the condensed chromatin of spermatozoa. Their transcription is first observed in stage I round spermatids and generally shut down in elongating spermatids. The mRNAs are then stored for later translation [26] . Recently it has been shown that expression of the protamine genes prm-1 and prm-2 is regulated by transcriptional interference between GCNF and the cAMPresponsive transcription factor CREMτ [27]. CREMτ is thought to have a key role during spermatogenesis because inactivation of CREMτ results in infertility in transgenic mice [28] . The cross-talk between GCNF and CREMτ signaling is also relevant for testis-specific transcription of two additional genes, mitochondrial glycerol-3-phosphate dehydrogenase and endozepine-like peptide. [29, 30] . Mitochondrial glycerol-3-phosphate dehydrogenase, which is localized to late spermatids and the mitochondriarich midpiece of spermatids, contributes to aerobic metabolism of sperms, powering their motility and thus their potential to fertilize [29] . Endozepine-like peptide is supposed to exert specific functions in the lipid metabolism of haploid male gametes, as it binds co-enzyme A-activated fatty acids [30] . In the present report, we found that GCNF is also able to repress the transcription activity of PPARδ promoter in mouse testis.
In the testis, the three PPAR isoforms are expressed in both somatic and germ cells [8, 31, 32] . PPARα and PPARδ are widely expressed in interstitial Leydig cells and seminiferous tubule cells (Sertoli and germ cells) [8] . The function of PPARδ in testis is unclear, but it does not seem to play an important role in fertility. Indeed, PPARδ null mice are viable and fertile [33] . Here, PPARδ mRNA was weakly found in cells closest to the basal lamina, including spermatogonia, early spermatocytes, and supporting Sertoli cells. mRNA signal was not detected in interstitial Leydig cells. And it seems that the transcription level of PPARδ was too low in mouse testis to be detected by in situ hybridization. In fact, mRNA of PPARδ was only able to be detected by reverse transcription-PCR in previous reports [32, 34] . It appears that there are some factors to repress the transcription of PPARδ gene in testis. In our study, we also carried out several experiments showing that GCNF directly represses PPARδ expression at the level of transcription. First, overexpressed GCNF can repress mouse PPARδ promoter activity in different cell lines, such as NIH 3T3 and COS7 (Fig. 2) . Second, point mutations in the putative GCNF binding sites in mouse PPARδ promoter also results in up-regulation of PPARδ promoter activity in vitro and in vivo, suggesting again that GCNF acts as a repressor in PPARδ promoter (Figs.  3 and 4) . Third, GCNF in the nuclear extracts of testis is directly able to bind the promoter of PPARδ (Fig. 5) and, moreover, the data implies that this binding is GCNFmediated on the putative GCNF binding site. Finally, we analyzed the promoter of PPARδ gene using online tools, and found that there are two cAMP-responsive transcription factor binding sites, gcgcggTGACatcacggggct (position −100) and agcgtgTGACgccgcaggccg (position −6) in the promoter. GCNF and CREMτ can also compete for binding to the cAMP-responsive element [29] and result in the depression of gene expression. It is interesting that the GCNF response element mutation promoter has lower activity in vivo than in vitro, suggesting that there might be more than a GCNF element in the promoter. The data show that GCNF might play roles in mouse testis through the regulation of PPARδ expression at transcription level. And it should be reasonable to suggest that GCNF could repress the expression of PPARδ in mouse testis.
In conclusion, our results show that the transcriptional activity of PPARδ promoter is repressed by GCNF overexpression in vitro and in vivo. Furthermore, GCNF in nuclear extract of testis can bind to the potent GCNF response element of PPARδ promoter. Although further investigation is required, GCNF could be part of a pathway that functions on PPARδ and represses other genes activated by PPARδ in testis.
